# GO	NS	enrichment	name	ratio_in_study	ratio_in_pop	p_uncorrected	depth	study_count	p_fdr_bh	study_items
GO:0019789	MF	e	SUMO transferase activity	8/8	13/6920	9.908506777775433e-24	6	8	2.5633307034105046e-20	KRE29, MMS21, NSE1, NSE3, NSE4, NSE5, SMC5, SMC6
GO:0019787	MF	e	ubiquitin-like protein transferase activity	8/8	134/6920	1.6041964829309155e-14	5	8	1.6592910740637304e-11	KRE29, MMS21, NSE1, NSE3, NSE4, NSE5, SMC5, SMC6
GO:0016755	MF	e	aminoacyltransferase activity	8/8	137/6920	1.9241875617283304e-14	4	8	1.6592910740637304e-11	KRE29, MMS21, NSE1, NSE3, NSE4, NSE5, SMC5, SMC6
GO:0016746	MF	e	acyltransferase activity	8/8	285/6920	7.526988192895567e-12	3	8	4.868079613755209e-09	KRE29, MMS21, NSE1, NSE3, NSE4, NSE5, SMC5, SMC6
GO:0140096	MF	e	catalytic activity, acting on a protein	8/8	712/6920	1.2122991711791087e-08	2	8	6.2724359116807085e-06	KRE29, MMS21, NSE1, NSE3, NSE4, NSE5, SMC5, SMC6
GO:0016740	MF	e	transferase activity	8/8	1029/6920	2.3355318047212647e-07	2	8	0.0001007003463135652	KRE29, MMS21, NSE1, NSE3, NSE4, NSE5, SMC5, SMC6
GO:0042030	MF	e	ATPase inhibitor activity	2/8	9/6920	4.193557818605034e-05	3	2	0.01385355088351402	KRE29, NSE5
GO:0140678	MF	e	molecular function inhibitor activity	3/8	65/6920	4.284051297569082e-05	2	3	0.01385355088351402	KRE29, MMS21, NSE5
